BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance

Advanced environmental performance through renewable energy transition and enhanced carbon transparency Strengthened sustainability management and suppl...

July 01, 2026 | News

PharmaResearch Expands U.S. Footprint with CG USA Acquisition to Boost REJURAN Cosmetics Growth

Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, ...

July 01, 2026 | News

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...

July 01, 2026 | Analysis

Samsung Bioepis and ATLATL Launch Innovation Prize to Accelerate Asia-Pacific Biotech Startups

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies ATLATL Innovation Center ("A...

June 26, 2026 | News

Samsung Bioepis and Organon Expand Canadian Biosimilars Alliance with PYZCHIVA® Commercialisation Agreement

Samsung Bioepis and Organon, a global healthcare company with a deep expertise in biosimilars, announced the expansion of their development and commer...

June 23, 2026 | News

LG AI Research and D&D Pharmatech Join Forces to Accelerate AI-Powered Oral Peptide Drug Discovery

- LG to secure leadership in the AI-bio market with its distinctive technological edge. LG AI Research announced that it has signed a ...

June 19, 2026 | News

Dimerix Signs Up to AU$481 Million Licensing Deal with Everest Medicines to Advance Phase 3 Kidney Disease Therapy Across Asia

Dimerix Limited (ASX: DXB), a biopharmaceutical company developing innovative therapies for rare inflammatory diseases, has entered into an exclusive licen...

June 17, 2026 | News

SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...

June 11, 2026 | News

Dayspring Pharma's CG2001 Meets Phase II Endpoint in Male Androgenetic Alopecia Trial

Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positiv...

June 09, 2026 | News

Chime Biologics And Daewoong Pharmaceutical Partner To Advance Global Dupilumab Biosimilar Development

VMS Group is pleased to share that our portfolio company, Chime Biologics, in which we are also the controlling shareholder, has announced a strategic...

June 09, 2026 | News

SK Bioscience Secures First UNICEF Influenza Vaccine Contract Across Both Hemispheres

First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets Dual-hemisphere supply programs enhance manu...

June 04, 2026 | News

Samsung Epis Holdings Establishes First Global R&D Hub in Beijing to Advance ADC and Novel Drug Development

Establishes its first global research base as part of strategic new business expansion under the holding company structure Ÿ B...

June 03, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

June 02, 2026 | News

Samsung Bioepis Launches OPUVIZ Aflibercept Biosimilar Across Europe

OPUVIZ™ 40 mg/mL solution for injection in a vial, a biosimilar referencing Eylea (aflibercept), will be rolled out across Europe, starting today...

June 01, 2026 | News

Stay Connected